Stocktwits on MSN
SLS stock in spotlight on EU expansion for cancer therapy – retail says potential catalyst for buyout
The European study is expected to enroll 40 newly diagnosed AML patients. ・Enrollment at U.S. sites is planned to begin in ...
Sellas Life Sciences faces high risk in the Phase 3 REGAL AML trial for GPS. Click here to know why I rate the SLS stock a ...
SELLAS Life Sciences Group ( (SLS)) just unveiled an update. Subsequent to December 31, 2025, SELLAS Life Sciences Group, a biopharmaceutical company, received approximately $26.5 million in cash ...
$SLS insiders have traded $SLS stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales. Here’s a ...
SELLAS Life Sciences Gr (NASDAQ:SLS) Stock, Option Chain Option chain shows key data for SELLAS Life Sciences Gr's stock options at various strike prices and expiration dates. Traders use this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results